Guidance for manufacturers of cardiac implantable electronic devices and their leads. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Similar Posts
Guidance: Medical devices: post-market surveillance requirements
How to interpret post-market surveillance (PMS) requirements for medical devices in Great Britain.
MHRA Safety Roundup: May 2025
Summary of the latest safety advice for medicines and medical device users
Consultation on the International Council for Harmonisation Guideline Q3E for Extractables and Leachables
The MHRA is consulting with UK stakeholders to gather feedback and comments on an international guideline on the assessment and control of extractables and leachables.
COVID-19 test approval: how to apply
How manufacturers or distributors of Coronavirus (COVID-19) test devices can apply for approval of their tests to be placed on the UK market.
Field Safety Notices: 15 – 19 December 2025
List of Field Safety Notices (FSNs) for week 15 – 19 December 2025
AI Airlock, CERSIs and a new global AI network for health regulators
Med Tech Regs blog, June 2025: A focus on Software and AI.